Sustained Benefit of Blinatumomab in Infants With KMT2A-Rearranged ALL: Long-Term Outcomes, Toxicity, and Pharmacokinetics Among N = 300 patients, 74.7% was female, 76.5% was White, and 19.0% was ...

Log in to your account to access your content on Nursing Times.

First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study Atlantic Canadian cancer survivors with insomnia and ...

Rhiannon Phillips receives funding from Welsh Government, Public Health Wales, Medical Research Council, Health and Care Research Wales, Cancer Research UK, and the National Institute for Health ...